Pharma 4.0

On today’s episode, Stacey Bruzzese welcomes Karen Ginsbury to talk about Pharma 4.0. They talk about what Pharma 4.0 is all about.

Stacey and Karen talk about a variety of topics:

What exactly is Pharma 4.0?
Have we reached or passed the tipping point for adoption?
What is included in Pharma 4.0?
What obstacles does Karen see for implementation of Pharma 4.0?
Karen gives a 2-minute explanation of whether Parma 4.0 is affordable and efficient
Does Karen think people will be worried that they don’t understand how Pharma 4.0 works?

Karen Ginsbury is President and CEO of PCI Pharmaceutical Consulting. She has over twenty years of experience in the pharmaceutical industry. After leaving Teva, Karen set up her own consultancy company, PCI Pharmaceutical Consulting Israel, Ltd. Which has been providing services to the pharmaceutical industry worldwide for the past 13 years.

Below are some links to help understand Pharma 4.0 topics:

TESLA

https://www.cnbc.com/2019/05/20/wedbu...

4th industrial revolution-Future of Health & Healthcare

https://www.weforum.org/platforms/sha...

Future of Advanced Manufacturing & Production

https://www.weforum.org/platforms/sha...

Future of Artificial Intelligence and Machine Learning

https://www.weforum.org/platforms/sha...

Credit Suisse article

https://www.credit-suisse.com/about-u...

Novartis Smart Factory

https://www.novartis.com/stories/disc...

FDA Doc:

https://www.dropbox.com/preview/cbi/I...

Pioneering Perspectives:

https://www.dropbox.com/preview/cbi/I...

Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.